Oracle Validated Integration Partners Offer Healthcare Organizations Fast Time to Value

Redwood Shores, Calif. – February 25, 2015 - Healthcare organizations are increasingly focused on streamlining data to meet a multitude of challenges, from regulatory compliance and reimbursement management to delivering quality care to their patients across the care continuum. Oracle today announced it has expanded its Oracle Validated Integration program to include the Oracle Healthcare platform, starting with Oracle Enterprise Healthcare Analytics. This expansion of the Oracle Validated Integration program will help healthcare organizations identify innovative healthcare analytic applications more quickly and subsequently deploy these partner solutions with less risk so they can focus on their core objective—improving patient care.

Oracle Validated Integration, available through Oracle PartnerNetwork (OPN), provides partners with a path for building and promoting repeatable integrations with solutions that complement and extend Oracle Applications. Healthcare organizations will be able to use preintegrated partner solutions with Oracle Health Sciences Enterprise Healthcare Analytics to help reduce deployment risk, accelerate time to value for critical decision making, and drive operational and financial improvements with exceptional patient outcomes and experience. Using Oracle Enterprise Healthcare Analytics, a leading healthcare enterprise-class data management platform, healthcare providers can enhance data transparency and obtain insights that allow them to improve patient safety, care quality, cost efficiency, and overall enterprise performance.

“Partners achieving Oracle Validated Integration with Oracle Healthcare can help healthcare organizations deploy critical healthcare analytics solutions more quickly and with less risk—ultimately accelerating programs that improve organizational efficiency and enhance patient care,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.

Oracle PartnerNetwork members Edgewater Ranzal, Grant Thornton, MedeAnalytics, and Perficient are among the initial partners participating in Oracle Validated Integration with Oracle Enterprise Healthcare Analytics. Perficient, Grant Thornton, and Edgewater Ranzal are delivering advanced healthcare cost accounting solutions preintegrated with Oracle Enterprise Healthcare Analytics. MedeAnalytics is delivering its Revenue Cycle solution with Oracle Enterprise Healthcare Analytics.

“Perficient is excited to be a plank owner in the Oracle Hyperion and Oracle Enterprise Healthcare Analytics integration effort. Our High-Performance Costing Expressway is the intersection of cost and quality of patient care,” said Emil Fernandez, vice president, Oracle National Business Unit, Perficient.

“Faced with new payment models and increased competition in the marketplace, large and small healthcare providers benefit from detailed insight into the costs associated with the care they deliver,” said Carl Yost, principal, Grant Thornton. “Grant Thornton’s Healthcare Costing Informatics (RxCI) solution, preintegrated with Oracle Enterprise Healthcare Analytics, allows healthcare providers to achieve actionable analytics quickly and in alignment with industry best practices. That insight allows them to make informed decisions that can increase their quality of care and positively impact operating results.”

“Edgewater Ranzal has chosen to preintegrate our Ranzal Healthcare Analytics (RHA) Costing solution with Oracle Enterprise Healthcare Analytics to provide healthcare providers advanced patient analytics,” said Mark Hite, healthcare practice director, Edgewater Ranzal. “The solution delivers the information necessary to support advanced costing down to the encounter level, including detailed attribution.”

“The combined solution of with Mede/Revenue Cycle provides customers with a single, integrated view of their organization’s financial data—enabling increased cash collections, reduction in bad debt, enhanced productivity, and actionable insight on enterprise business strategy,” said Melissa Ross, vice president of business development, MedeAnalytics.

With these preintegrated offerings, healthcare organizations can quickly deploy and derive value from a broad set of analytics applications that can help extend the Oracle Healthcare platform.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.